Applications including "Draft for the Japanese Pharmacopoeia"

LC252 - Analysis of Sertraline hydrochloride (Under the Condition of draft for Japanese Pharmacopoeia, Sertraline Hydrochloride Tablets, DISSOLUTION) -

LC InertSearch Inertsil WP300 C18
LC251 - Analysis of Sertraline hydrochloride (Under the Condition of draft for Japanese Pharmacopoeia, Sertraline Hydrochloride, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC148 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(3), Related Substances 3) -

LC InertSearch Inertsil ODS-4
LC147 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(2), Related Substances 2) -

LC InertSearch InertSustain AQ-C18
LC146 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(1), Related Substances 1) -

LC InertSearch InertSustain C18
LC145 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia , Solifenacin Succinate, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -

LC InertSearch InertSustain Cyano
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LC InertSearch InertSustain C18
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LC InertSearch InertSustain C18
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LC InertSearch Inertsil ODS-3
LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LC InertSearch Inertsil ODS-4
LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LC Technical Note Inertsil ODS-SP
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LC InertSearch InertSustain C18
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LC InertSearch InertSustain C18
LB527 - Analysis of Dexamethasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB526 - Analysis of Dexamethasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C18
LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LC InertSearch InertSustain Cyano
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C8
LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -

LC InertSearch InertSustainSwift C18 HP
LB446 - Analysis of Hydrocortisone butyrate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3 HP
LB444 - Analysis of Pazufloxacin mesilate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB415 - Analysis of Methotrexate (Under the Condition of the draft for the Japanese Pharmacopoeia, Methotrexate Tablets) -

LC InertSearch Inertsil ODS-4
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB409 - Analysis of Mesalazine (Under the Condition of the draft for the Japanese Pharmacopoeia, Mesalazine Extended-release Tablets) -

LC InertSearch Inertsil ODS-4
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -

LC InertSearch InertSustain C18
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C18
LB106 - Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
GA275 - Analysis of Hydroxypropyl Cellulose(Under the Condition of the draft for the Japanese Pharmacopoeia) -

GC InertSearch InertCap 1
GA274 - Analysis of Tulobuterol Transdermal Tapes(Under the Condition of the draft for the Japanese Pharmacopoeia) -

GC InertSearch InertCap 1

Applications including "Draft for the Japanese Pharmacopoeia"

LC252 - Analysis of Sertraline hydrochloride (Under the Condition of draft for Japanese Pharmacopoeia, Sertraline Hydrochloride Tablets, DISSOLUTION) -

LC251 - Analysis of Sertraline hydrochloride (Under the Condition of draft for Japanese Pharmacopoeia, Sertraline Hydrochloride, ASSAY) -

LC148 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(3), Related Substances 3) -

LC147 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(2), Related Substances 2) -

LC146 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(1), Related Substances 1) -

LC145 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia , Solifenacin Succinate, ASSAY) -

LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -

LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LB527 - Analysis of Dexamethasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LB526 - Analysis of Dexamethasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -

LB446 - Analysis of Hydrocortisone butyrate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB444 - Analysis of Pazufloxacin mesilate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB415 - Analysis of Methotrexate (Under the Condition of the draft for the Japanese Pharmacopoeia, Methotrexate Tablets) -

LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB409 - Analysis of Mesalazine (Under the Condition of the draft for the Japanese Pharmacopoeia, Mesalazine Extended-release Tablets) -

LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -

LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -

LB106 - Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) -

GA275 - Analysis of Hydroxypropyl Cellulose(Under the Condition of the draft for the Japanese Pharmacopoeia) -

GA274 - Analysis of Tulobuterol Transdermal Tapes(Under the Condition of the draft for the Japanese Pharmacopoeia) -

Application Search